Goss V L, Hocevar B A, Thompson L J, Stratton C A, Burns D J, Fields A P
Department of Pharmacology, Case Western Reserve University School of Medicine, Cleveland, Ohio 44106.
J Biol Chem. 1994 Jul 22;269(29):19074-80.
Multisite phosphorylation of the nuclear lamins is thought to regulate the process of mitotic nuclear envelope breakdown in vivo. Here we investigate the involvement of two proposed human mitotic lamin kinases, beta II protein kinase C (PKC) and p34cdc2/cyclin B kinase, in human lamin B1 phosphorylation in vitro and in intact cells. We find that both kinases can phosphorylate purified soluble lamin B at similar rates. However, beta II PKC phosphorylates interphase nuclear envelope lamin B at more than 200 times the rate of human p34cdc2/cyclin B kinase. beta II PKC-mediated phosphorylation of lamin B is confined to two sites, Ser395 and Ser405, within the carboxyl-terminal domain, whereas human p34cdc2/cyclin B kinase phosphorylates a single site, Ser23, in the amino-terminal domain. A second potential p34cdc2/cyclin B kinase site within the carboxyl-terminal domain, Ser393, is not phosphorylated by human p34cdc2/cyclin B kinase. However, invertebrate p34cdc2/cyclin B kinase from sea star exhibits a different specificity, phosphorylating both amino- and carboxyl-terminal sites. Mitotic human lamin B from intact cells is phosphorylated predominantly in its carboxyl-terminal domain. Comparative tryptic phosphopeptide mapping demonstrates that the beta II PKC site, Ser405, is a prominent target of mitotic lamin B phosphorylation in vivo. beta II PKC translocates to the nucleus during the G2/M phase of cell cycle concomitant with phosphorylation of Ser405, indicating a physiologic role for nuclear beta II PKC activation in mitotic lamin B phosphorylation in vivo. The presence of phosphorylation sites within the carboxyl-terminal domain of mitotic lamin B which are not phosphorylated by either beta II PKC or p34cdc2/cyclin B kinase suggests the involvement of other lamin kinase(s) in G2/M phase lamin B phosphorylation.
核纤层蛋白的多位点磷酸化被认为在体内调节有丝分裂期核膜破裂的过程。在此,我们研究了两种被认为的人类有丝分裂核纤层蛋白激酶,βII蛋白激酶C(PKC)和p34cdc2/细胞周期蛋白B激酶,在体外和完整细胞中对人类核纤层蛋白B1磷酸化的作用。我们发现这两种激酶都能以相似的速率磷酸化纯化的可溶性核纤层蛋白B。然而,βII PKC磷酸化间期核膜核纤层蛋白B的速率是人类p34cdc2/细胞周期蛋白B激酶的200多倍。βII PKC介导的核纤层蛋白B磷酸化局限于羧基末端结构域内的两个位点,即Ser395和Ser405,而人类p34cdc2/细胞周期蛋白B激酶磷酸化氨基末端结构域内的一个位点Ser23。羧基末端结构域内的第二个潜在p34cdc2/细胞周期蛋白B激酶位点Ser393,未被人类p34cdc2/细胞周期蛋白B激酶磷酸化。然而,来自海星的无脊椎动物p34cdc2/细胞周期蛋白B激酶表现出不同的特异性,能磷酸化氨基末端和羧基末端位点。来自完整细胞的有丝分裂期人类核纤层蛋白B主要在其羧基末端结构域被磷酸化。比较胰蛋白酶磷酸肽图谱表明,βII PKC位点Ser405是体内有丝分裂期核纤层蛋白B磷酸化的主要靶点。βII PKC在细胞周期的G2/M期转位至细胞核,同时Ser405发生磷酸化,表明核βII PKC激活在体内有丝分裂期核纤层蛋白B磷酸化中具有生理作用。有丝分裂期核纤层蛋白B羧基末端结构域内存在未被βII PKC或p34cdc2/细胞周期蛋白B激酶磷酸化的磷酸化位点,这表明其他核纤层蛋白激酶参与了G2/M期核纤层蛋白B的磷酸化。